Tuesday, February 5, 2013

• Cancer Radiation Stocks To Consider: Delcath, Spectrum And IsoRayat Seeking Alpha (Tue, Feb 5)
• Spectrum Pharmaceuticals: Here's One Acquisition Rumor That I Wouldn't Mind Chasingat Seeking Alpha (Tue, Feb 5)

Monday, February 4, 2013

• Spectrum Acquires Apaziquone RightsZacks (Mon, Feb 4)

Thursday, January 31, 2013

• A Reacquired Drug Lottery Ticketat Motley Fool (Thu, Jan 31)
• 4 Companies With High Upside And Large Short Interestat Seeking Alpha (Thu, Jan 31)
• Spectrum rises on bladder cancer drug updateAP (Thu, Jan 31)
• Spectrum Pharma's Bladder Cancer Bamboozleat TheStreet (Thu, Jan 31)
• Total of 676 Biotech and Pharma Takeovers in the Past 3 Years -- M&A Activity Expected to Rise in 2013Marketwired (Thu, Jan 31)
• Why Spectrum Pharma Is Poised to Outperformat Motley Fool (Thu, Jan 31)
• SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online (Thu, Jan 31)
• Spectrum Pharmaceuticals Acquires Rights for Apaziquone in the U.S., Europe and Other Territories from Allergan; Expects to File New Drug ApplicationBusiness Wire (Thu, Jan 31)

Tuesday, January 29, 2013

• Positive Data on Spectrum CandidateZacks (Tue, Jan 29)
• Buy, Sell, or Hold: Keryx Biopharmaceuticalsat Motley Fool (Tue, Jan 29)

Monday, January 28, 2013

• 4 Healthcare Stock Stories Not to be Missedat Wall St. Cheat Sheet (Mon, Jan 28)
• Growing Use Of Radiopharmaceuticals For Fighting Cancer Shows Promiseat Seeking Alpha (Mon, Jan 28)
• Spectrum Pharmaceuticals Announces Presentation of Belinostat Safety Profile from BELIEF Registrational Phase 2 Trial at the Fifth Annual T-Cell Lymphoma ForumBusiness Wire (Mon, Jan 28)

Wednesday, January 23, 2013

• Five Healthcare Stocks With Mass Movementat Motley Fool (Wed, Jan 23)

Tuesday, January 22, 2013

• Patent Extension at Spectrum PharmaZacks (Tue, Jan 22)

Saturday, January 19, 2013

• 3 Questions for Spectrum in 2013at Motley Fool (Sat, Jan 19)

Thursday, January 17, 2013

• The New Biotech Media Blitzat Motley Fool (Thu, Jan 17)
• Spectrum Pharmaceuticals Announces Extension of FUSILEV® (levoleucovorin) for Injection Patent Until 2022Business Wire (Thu, Jan 17)

Tuesday, January 15, 2013

• Spectrum initiated with a Neutral at Credit Suissetheflyonthewall.com (Tue, Jan 15)

Monday, January 14, 2013

• Biotech Stock Lessons From 2013 J.P. Morgan Healthcare Confabat TheStreet (Mon, Jan 14)

Friday, January 11, 2013

• S&P 1500 Most Heavily Shorted Stocksat Seeking Alpha (Fri, Jan 11)
• Spectrum Pharmaceuticals Announces Promotion of Joseph Turgeon to Senior Vice President and Chief Commercial Officer as Company Builds on Recent Commercial Reorganization to Advance Growth and Market Penetration over the Next Five YearsBusiness Wire (Fri, Jan 11)

Add SPPI News to My Yahoo!